Recurrent and resistant angina: Is the metabolic approach an appropriate answer?

Coronary Artery Disease

Volumn 15, Issue SUPPL. 1, 2004, Pages

  Marzilli, Mario ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Metabolic approach; Ranolazine; Recurrent angina; Stable angina; Trimetazidine

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FATTY ACID; RANOLAZINE; TRIMETAZIDINE;

ANGINA PECTORIS; CALCIUM HOMEOSTASIS; CLINICAL TRIAL; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE COURSE; DRUG EFFICACY; ENERGY METABOLISM; EXERCISE TOLERANCE; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; META ANALYSIS; METABOLISM; MORBIDITY; PATHOGENESIS; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME;

ANGINA PECTORIS; CHRONIC DISEASE; ENZYME INHIBITORS; HUMANS; MYOCARDIAL REVASCULARIZATION; RECURRENCE; VASODILATOR AGENTS;

EID: 3042754491     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. American Heart Association. Heart Disease and Stroke Statistics: 2003 Update. Dallas: American Heart Association; 2002.
2. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 1999; 33:2092-2197.
3. Pepine CL, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E. J Am Coll Cardiol 1994; 74:226-231.
4. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease: a multicenter randomized trial. JAMA 1997; 277:715-721.
5. Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KA, Julian DG, et al. Seven-year outcome in the RITA-2 trial: Coronary angioplasty versus medical treatment. J Am Coll Cardiol 2003; 42:1161-1170.
6. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angiopiasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 2000; 321:73-77.
7. Hemingway H, Crook AM, Feder G, Banerjee S, Dawson JR, Magee P, et al. Underuse of revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 2001; 344: 645-654.
8. Serruys PW, Unger F, Sousa JE, Jakene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124.
9. Blumenthal RS, Cohn G, Schulman SP. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature. J Am Coll Cardiol 2000; 36:668-673.
10. Sambuceti G, Marzilli M, Fedele S, Marini C, L'Abbate A. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease. Circulation 2001; 103:2352-2360.
11. Marzilli M, Sambuceti G, Testa R, Fedele S. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. J Am Coll Cardiol 2002; 40:2102-2109.
12. Stanley WC. Partial inhibition of cardiac fatty acid oxidation for the treatment of chronic stable angina. Expert Opin Investig Drugs 2002; 11:1-15.
13. Stanley WC, Marzilli M. Metabolic therapy in the treatment of ischemic heart disease: the pharmacology of trimetazidine. Fundam Clin Pharmacol 2003; 17:133-145.